INTRODUCTION
============

Elevated blood pressure is a major preventable cause for cardiovascular diseases, including ischemic heart disease, stroke, heart failure, atrial fibrillation, and peripheral arterial disease, and a leading cause of all-cause mortality worldwide.[@B1] Lifestyle modification is important for the prevention and treatment of elevated blood pressure. This includes weight loss,[@B2] increased physical activity,[@B3] and reduced alcohol consumption,[@B4] which can reduce cardiovascular disease risk.

Alcohol is mainly metabolized by alcohol dehydrogenase (ADH) and acetaldehyde dehydrogenase. There are genetic differences in these enzymes in different ethnic groups. The aldehyde dehydrogenase 2 (*ALDH2*) variant is common in East Asians, and the activity of ALDH2 varies by about 3--5 fold according to rs671,[@B5] a missense *ALDH2* mutation. Mutations in *ALDH2* are closely related to the avoidance of alcohol drinking. Inactive *ALDH2* causes alcohol flush reactions such as erythema, nausea, and rapid heart rate as a result of aldehyde accumulation after alcohol consumption.[@B6][@B7] Active *ALDH2* carriers who do not develop alcohol flushing tend to be drinkers with a greater amount of alcohol intake.[@B8][@B9][@B10]

Many previous studies have evaluated the association between the *ALDH2* rs671 polymorphism and blood pressure.[@B9][@B11][@B12][@B13][@B14][@B15][@B16] In some studies,[@B9][@B11][@B12][@B14][@B16] the *ALDH2* genotype was considered as an instrumental variable of alcohol consumption. However, the *ALDH2* genotype modifies the effects of alcohol via aldehyde accumulation. Therefore, it is necessary to evaluate the relationship between alcohol consumption and blood pressure through stratification analyses according to the *ALDH2* genotype. In this study, we evaluated the associations between alcohol consumption and blood pressure and hypertension after stratifying the *ALDH2* genotype.

METHODS
=======

Study population
----------------

This study was based on the Dong-gu Study, the framework of which has been described elsewhere.[@B17] Briefly, the Dong-gu Study involved 9.260 participants aged ≥ 50 years who live in Gwangju, the metropolitan city in Korea. Of these, 495 participants with myocardial infarction or stroke were excluded. *ALDH2* genotyping was missing for 31 participants and information on alcohol consumption was missing for 131 participants. Ultimately, 8,526 participants without missing values were included in the analyses.

Blood pressure measurement and definition of hypertension
---------------------------------------------------------

Blood pressure was measured by trained investigators three times at the right upper arm using a mercury sphygmomanometer after the participants had rested for ≥ 5 minutes. We used the mean of the three blood pressure measurements in the analyses. Hypertension was defined as either systolic blood pressure (SBP) ≥ 140 mmHg or diastolic blood pressure (DBP) ≥ 90 mmHg or taking antihypertensive medication.

Assessment of lifestyles and comorbidities
------------------------------------------

Information on variables such as lifestyle and disease history was obtained through interview questionnaires. The frequency and amount per occasion of alcohol consumption were investigated; a non-drinker was defined as a participant who consumed less than one drink per month. Alcohol consumption was coded as non-drinker, less than one standard drink per day, or one or more standard drinks per day. Smoking status was coded as never, ex-smoker, or current smoker. Physical activity was coded as walking for at least 30 minutes on at least 5 days per week or not. Body mass index (BMI) was calculated in kilograms per meter squared from weight and height measured in a standing position without shoes. A history of diabetes was assessed using questionnaires.

Genotyping
----------

Genomic DNA was extracted from peripheral blood using a QIAamp DNA Blood Mini Kit (QIAGEN, Valencia, CA, USA), according to the manufacturer\'s protocol. rs671 was genotyped by high-resolution melting (HRM) analyses, using a Rotor-Gene 6000TM (Corbett Research, Sydney, Australia). The forward primer (5′-TTGGTGGCTACAAGATGTCG-3′) and reverse primer (5′-CAGGTCCCACACTCACAGTTT-3′) polymerase chain reaction (PCR) primers producing a 97-bp amplicon. The reaction mixture for HRM included 200 nM PCR primers, 1 µM SYTO 9 fluorescent dye (Invitrogen, Carlsbad, CA, USA), 0.5U F‐Star *Taq* DNA polymerase (BioFACT), and 40 ng genomic DNA in 10 µL reaction volumes. The cycling conditions comprised an initial denaturation at 95°C for 5 minutes, followed by 40 cycles of 95°C for 5 seconds and 58°C for 30 seconds.

Statistical analysis
--------------------

The baseline characteristics of the study population are presented according to gender and *ALDH2* genotype. General characteristics are expressed as means ± standard deviations or number (%). The general characteristics of the participants were compared using *t*-tests for continuous variables, and χ^2^ tests for categorical data. Genotype was categorized as active *ALDH2* (GG) and inactive *ALDH2* (GA/AA). All analyses were carried out by gender. Multivariate linear regression was performed to assess the associations between *ALDH2* and alcohol consumption and SBP and DBP. Multivariate logistic regression was performed to assess the associations between *ALDH2* genotypes and alcohol consumption and hypertension.

Ethics statement
----------------

This study was approved by the Institutional Review Board (IRB) of Chonnam National University Hospital (IRB No. I-2008-05-056), and informed consent was obtained from each subject.

RESULTS
=======

[Table 1](#T1){ref-type="table"} shows the baseline characteristics according to the *ALDH2* genotype and gender. The GG, GA, and AA genotype frequencies were 69.0%, 28.4%, and 2.6%, respectively, and were in Hardy--Weinberg equilibrium (*P* = 0.141). Inactive *ALDH2* carriers were significantly older and had a lower alcohol consumption and lower DBP than active *ALDH2* carriers in both genders. They had a lower BMI and SBP and a higher prevalence of hypertension, and diabetes only in men.

###### General characteristics of study subjects according to genotype of *ALDH2* rs671

![](jkms-35-e14-i001)

  Characteristics                  Men              Women                                                     
  -------------------------------- ---------------- -------------- ------------ -------------- -------------- ----------
  Total                            2,242 (67.6)     1,077 (32.4)                3,638 (69.9)   1,569 (30.1)   
  Age, yr                          65.6 ± 8.0       67.0 ± 7.9     \< 0.001     64.1 ± 8.1     64.8 ± 8.3     0.005
  Smoking status                                                   0.569                                      0.020
                                   Never smoker     570 (25.4)     283 (26.3)   3,491 (96.0)   1,530 (97.5)   
                                   Ex-smoker        1,116 (49.8)   515 (47.8)   67 (1.8)       19 (1.2)       
                                   Current smoker   556 (24.8)     279 (25.9)   80 (2.2)       20 (1.3)       
  Physical activity                601 (26.8)       272 (25.3)     0.342        465 (12.8)     202 (12.9)     0.927
  Alcohol consumption, drink/day                                   \< 0.001                                   \< 0.001
                                   Non-drinker      535 (23.9)     686 (63.7)   2,789 (76.7)   1,475 (94.0)   
                                   \< 1             589 (26.3)     271 (25.2)   716 (19.7)     85 (5.4)       
                                   ≥ 1              1,118 (49.9)   120 (11.1)   133 (3.7)      9 (0.6)        
  Drinks/day                       2.0 (2.6)        0.4 (1.1)      \< 0.001     0.1 (0.5)      0.0 (0.2)      \< 0.001
  Hypertension                     1,048 (46.7)     440 (40.9)     0.001        1,559 (42.9)   657 (41.9)     0.512
  Diabetes                         576 (25.7)       184 (17.1)     \< 0.001     563 (15.5)     238 (15.2)     0.778
  BMI, kg/m^2^                     24.0 ± 2.8       23.6 ± 2.8     \< 0.001     24.6 ± 3.0     24.6 ± 2.9     0.399
  SBP, mmHg                        125.6 ± 16.4     122.5 ± 16.8   \< 0.001     122.4 (17.0)   122.0 (16.7)   0.451
  DBP, mmHg                        76.0 ± 10.6      74.6 ± 10.5    \< 0.001     73.8 (9.9)     72.9 (9.8)     0.003

All values are given as mean ± standard deviation or number (%).

*ALDH2* = aldehyde dehydrogenase 2, BMI = body mass index, SBP = systolic blood pressure, DBP = diastolic blood pressure.

[Table 2](#T2){ref-type="table"} shows the odds ratios (ORs) for hypertension in participants who were inactive *ALDH2* carriers compared to active *ALDH2* carriers. In the crude model, the ORs in men and women were 1.27 (95% confidence interval \[CI\], 1.10--1.47) and 1.04 (95% CI, 0.92--1.17), respectively. After adjusting for age, the risk difference was greater in model 1, and the ORs were 1.34 (95% CI, 1.16--1.56) in men and 1.09 (95% CI, 0.96--1.23) in women. In the final model, the ORs were 1.24 (95% CI, 1.06--1.45) in men and 1.08 (95% CI, 0.95--1.22) in women.

###### Association between *ALDH2* rs671 polymorphism and HTN according to gender

![](jkms-35-e14-i002)

  Variables   HTN (−)   HTN (+)        Crude model    Model 1             Model 2             *P* for interaction^a^   
  ----------- --------- -------------- -------------- ------------------- ------------------- ------------------------ -------
  Men                                                                                                                  
              GG        1,194 (65.2)   1,048 (70.4)   1.27 (1.10--1.47)   1.34 (1.16--1.56)   1.24 (1.06--1.45)        
              GA/AA     637 (34.8)     440 (29.6)     1 (Ref.)            1 (Ref.)            1 (Ref.)                 
  Women                                                                                                                
              GG        2,079 (69.5)   1,559 (70.4)   1.04 (0.92--1.17)   1.09 (0.96--1.23)   1.08 (0.95--1.22)        
              GA/AA     912 (30.5)     657 (29.7)     1 (Ref.)            1 (Ref.)            1 (Ref.)                 0.116

All values are given as odds ratio (95% confidence interval) or number (%).

Model 1 was adjusted for age. Model 2 was further adjusted for smoking, physical activity, diabetes mellitus, and body mass index.

*ALDH2* = aldehyde dehydrogenase 2, HTN = hypertension.

^a^*P* value for interaction term between gender and *ALDH2* rs671 genotype in model 2.

[Table 3](#T3){ref-type="table"} shows the SBP and DBP according to *ALDH2* genotypes and gender. The association between SBP and *ALDH2* genotype was modified by gender (*P* for interaction = 0.002). In men, inactive *ALDH2* carriers had a lower SBP and DBP, while in women, SBP did not differ significantly according to *ALDH2* genotype, and inactive *ALDH2* carriers genotype had a lower DBP.

###### Association between *ALDH2* rs671 polymorphism and blood pressure according to gender

![](jkms-35-e14-i003)

  Variables                SBP         DBP                                                                 
  ------------------------ ----------- ------------- ------------- ------------- ------------ ------------ ------------
  Men                                                                                                      
                           GG          125.6 ± 0.4   125.7 ± 0.3   125.6 ± 0.4   76.0 ± 0.2   76.0 ± 0.2   76.0 ± 0.2
                           GA/AA       122.5 ± 0.5   122.2 ± 0.5   122.5 ± 0.5   74.6 ± 0.3   74.6 ± 0.3   74.6 ± 0.3
                           *P* value   \< 0.001      \< 0.001      \< 0.001      \< 0.001     \< 0.001     \< 0.001
  Women                                                                                                    
                           GG          122.4 ± 0.3   122.5 ± 0.3   122.4 ± 0.3   73.8 ± 0.2   73.8 ± 0.2   73.8 ± 0.2
                           GA/AA       122.0 ± 0.4   121.8 ± 0.4   121.8 ± 0.4   72.9 ± 0.3   73.0 ± 0.3   73.0 ± 0.3
                           *P* value   0.451         0.155         0.196         0.003        0.007        0.009
  *P* for interaction^a^                             0.002                                    0.537        

Values are given as adjusted mean ± standard error.

Model 1 was adjusted for age. Model 2 was further adjusted for smoking, physical activity, diabetes mellitus, and body mass index.

*ALDH2* = aldehyde dehydrogenase 2, SBP = systolic blood pressure, DBP = diastolic blood pressure.

^a^*P* value for interaction term between gender and *ALDH2* rs671 genotype in model 2.

[Table 4](#T4){ref-type="table"} shows the association between alcohol consumption and the risk of hypertension according to *ALDH2* genotypes and gender. The association between alcohol consumption and risk of hypertension was only significant in men who had the active *ALDH2* genotype, while not significant in women.

###### Association between alcohol consumption and HTN, stratified by gender and *ALDH2* rs671 genotype
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  Variables                Men                          Women                                                                                                
  ------------------------ ---------------------------- ------------ ------------ ------------------- ------------------- -------------- ------------------- -------------------
  GG genotype                                                                                                                                                
                           Non-drinker                  304 (56.8)   231 (43.2)   1 (Ref.)            1,573 (56.4)        1,216 (43.6)   1 (Ref.)            
                           Current drinker, drink/day   890 (52.1)   817 (47.9)   1.33 (1.08--1.64)   506 (59.6)          343 (40.4)     1.05 (0.89--1.24)   
                                                        \< 1         316 (53.7)   273 (46.3)          1.16 (0.91--1.49)   434 (60.6)     282 (39.4)          1.00 (0.84--1.20)
                                                        ≥ 1          574 (51.3)   544 (48.7)          1.44 (1.15--1.80)   72 (54.1)      61 (45.9)           1.30 (0.90--1.87)
                           *P* value for trend^a^                                 0.001                                                  0.344               
  GA/AA genotype                                                                                                                                             
                           Non-drinker                  404 (58.9)   282 (41.1)   1 (Ref.)            851 (57.7)          624 (42.3)     1 (Ref.)            
                           Current drinker, drink/day   233 (59.6)   158 (40.4)   1.12 (0.85--1.46)   61 (64.9)           33 (35.1)      1.02 (0.64--1.63)   
                                                        \< 1         163 (60.1)   108 (39.9)          1.05 (0.77--1.42)   55 (64.7)      30 (35.3)           1.00 (0.61--1.64)
                                                        ≥ 1          70 (58.3)    50 (41.7)           1.29 (0.85--1.96)   6 (66.7)       3 (33.3)            1.25 (0.28--5.55)
                           *P* value for trend^a^                                 0.279                                                  0.874               
  *P* for interaction^b^                                             0.247                                                0.791                              

All models were adjusted for age, smoking history, physical activity, diabetes mellitus, and body mass index.

*ALDH2* = aldehyde dehydrogenase 2, HTN = hypertension, OR = odds ratio, CI = confidence interval.

^a^Trend test from non-drinker, \< 1 drink/day, to ≥ 1 drink/day; ^b^*P* value for interaction term between alcohol consumption (non-drinker and current drinker) and *ALDH2* rs671 genotype.

[Table 5](#T5){ref-type="table"} shows the dose-response relationship between alcohol consumption and blood pressure for each *ALDH2* genotype. The *ALDH2* genotype modified the association between alcohol consumption and SBP (*P* for interaction \< 0.001) and DBP (*P* for interaction = 0.007) in men, but not in women. The association between alcohol consumption and blood pressure was not significant in women, while in men, both SBP and DBP increased with alcohol consumption in the active *ALDH2* carrier. By contrast, the inactive *ALDH2* carrier was not related to alcohol consumption or blood pressure.

###### Association between alcohol consumption and blood pressure, stratified by *ALDH2* rs671 genotype

![](jkms-35-e14-i005)

  Variables                Men                          Women                                                                                  
  ------------------------ ---------------------------- -------------- -------------- ------------- -------------- ------------- ------------- ------------
  GG genotype                                                                                                                                  
                           Non-drinker                  535 (23.9)     121.9 ± 0.7    74.3 ± 0.4    2,789 (76.7)   122.3 ± 0.3   73.7 ± 0.2    
                           Current drinker, drink/day   1,707 (76.1)   126.7 ± 0.4    76.5 ± 0.2    849 (23.3)     122.6 ± 0.6   74.2 ± 0.3    
                                                        \< 1           589 (26.3)     125.1 ± 0.7   75.6 ± 0.4     716 (19.7)    122.2 ± 0.6   74.0 ± 0.4
                                                        ≥ 1            1,118 (49.9)   127.6 ± 0.5   77.1 ± 0.3     133 (3.7)     124.3 ± 1.4   75.0 ± 0.8
                           *P* value for trend^a^                      \< 0.001       \< 0.001                     0.414         0.146         
  GA/AA genotype                                                                                                                               
                           Non-drinker                  686 (63.7)     122.6 ± 0.6    74.4 ± 0.4    1,475 (94.0)   121.8 ± 0.4   72.9 ± 0.2    
                           Current drinker, drink/day   391 (36.3)     122.4 ± 0.8    74.8 ± 0.5    94 (6.0)       125.1 ± 1.7   74.2 ± 1.0    
                                                        \< 1           271 (25.2)     122.3 ± 1     74.6 ± 0.6     85 (5.4)      125.0 ± 1.8   74.3 ± 1.1
                                                        ≥ 1            120 (11.1)     122.7 ± 1.5   75.1 ± 0.9     9 (0.6)       126.2 ± 5.4   72.9 ± 3.2
                           *P* value for trend^a^                      0.954          0.530                        0.055         0.269         
  *P* for interaction^b^                                \< 0.001       0.007                        0.112          0.488                       

Values are adjusted mean ± standard error after adjusting for age, smoking history, physical activity, diabetes mellitus, and body mass index.

*ALDH2* = aldehyde dehydrogenase 2, SBP = systolic blood pressure, DBP = diastolic blood pressure.

^a^Trend test from non-drinker, \< 1 drink/day, to ≥ 1 drink/day; ^b^*P* value for interaction term between alcohol consumption (non-drinker and current drinker) and *ALDH2* rs671 genotype.

DISCUSSION
==========

In this study, active *ALDH2* carriers were associated with a high risk of hypertension in men. The association between alcohol consumption and SBP was dose-dependent in active *ALDH2* carriers. However, there was no significant association between the *ALDH2* polymorphism and hypertension and blood pressure in women.

In previous studies, active *ALDH2* carriers had a higher risk for hypertension than inactive *ALDH2* carriers.[@B9][@B11][@B12][@B13][@B16] The difference in blood pressure according to the activity of ALDH2 can be explained by the difference in alcohol consumption. In previous studies, active *ALDH2* carriers included a high prevalence of drinkers or greater alcohol consumption.[@B8][@B9][@B10] In our study, compared to inactive *ALDH2* carriers, active *ALDH2* carriers have 1.7 more drinks per day in men. In women, however, the amount of alcohol consumption was so small that the difference in consumption by the *ALDH2* genotype was not significant.[@B16] By contrast, Zhang et al.[@B14] found no significant association between *ALDH2* genotype and blood pressure in both never and current drinkers. In their study, there was an overadjustment bias due to the unnecessary adjustment of the frequency of alcohol consumption, an intermediate variable, in the association between *ALDH2* genotype and blood pressure.[@B18] In our study, active *ALDH2* carriers had a 3.1 mmHg higher SBP and 1.4 mmHg higher DBP than inactive *ALDH2* carriers in men. Ota et al.[@B15] reported a 3.3 mmHg higher SBP and 2.6 mmHg higher DBP in active *ALDH2* carriers compared to inactive *ALDH2* carriers. In the study of Isomura et al.,[@B12] the SBP and DBP of active *ALDH2* carriers were 1.8 and 1.3 mmHg higher than those of inactive *ALDH2* carriers, respectively. We also found a dose-response relationship between alcohol consumption and blood pressure in active *ALDH2* carriers. Similarly, meta-analysis studies of observational studies and clinical trials found a positive dose-response relationship between the amount of alcohol consumption and incidence of hypertension,[@B19] and reducing alcohol consumption led to lower blood pressure.[@B4] Chronic alcohol consumption increases blood pressure via increased sympathetic nerve activity, reduced antioxidants, and impaired vascular relaxation.[@B20]

In our study, the *ALDH2* genotype modified the association between alcohol consumption and blood pressure. There were dose-response relationships between alcohol consumption and SBP and DBP in active *ALDH2* carriers, but no significant relationship in inactive *ALDH2* carriers. In inactive *ALDH2* carriers, it is not clear why blood pressure did not increase with the amount of alcohol consumption. Based on our results, we postulate that other blood pressure lowering effects of ethanol metabolites, such as aldehyde, counteract the ethanol-induced blood pressure increase. After alcohol consumption, inactive *ALDH2* carriers have a fivefold higher peak blood aldehyde level than active *ALDH2* carriers. Aldehyde lowers blood pressure in the early phase after drinking alcohol. In an animal study, an inactive *ALDH2*-like disulfiram-treated group had a lower blood pressure than a control group after ethanol administration.[@B21] Few studies have evaluated the dose-response relationship between alcohol consumption and blood pressure according to the *ALDH2* genotype. In contrast with our results, Ota et al.[@B15] reported a significant positive association between the amount of alcohol consumption and SBP only in inactive *ALDH2* carriers. However, their study population was small and consisted of only men workers with high alcohol consumption.

In inactive *ALDH2* carriers, the difference in the amount of alcohol consumption among categories of alcohol consumption was not sufficiently large, so the association between alcohol consumption and blood pressure may not have been evaluated sufficiently. Drinkers who are inactive *ALDH2* carriers consume less alcohol than drinkers who are active *ALDH2* carriers.[@B10] Because the difference in alcohol consumption between drinkers and non-drinkers in the inactive *ALDH2* carrier is less than that of the active *ALDH2* carrier, the effects of drinking on the increase in blood pressure were weak in inactive *ALDH2* carriers. In our study, of those who drank more than one drink per day, those with the inactive *ALDH2* genotype drank 2.88 drinks per day, whereas those with the active *ALDH2* genotype had 3.89 drinks per day. The binge-drinking rate was 64.5% in the drinkers with the active *ALDH2* genotype, but 28.5% in those with the inactive genotype (data not shown).

The main strength of our study was the large sample size, which enabled us to evaluate the association between alcohol consumption and blood pressure according to *ALDH2* genotypes. The limitation of our study is that other polymorphisms affecting alcohol metabolism, such as ADH 1B (*ADH1B*), were not evaluated in this study. However, *ADH1B* polymorphism was not significantly associated with a high risk of hypertension[@B13] or high blood pressure[@B14] in previous studies.

In conclusion, there was a positive dose-response relationship between alcohol consumption and blood pressure in active, but not in inactive, *ALDH2* carriers. Further studies are needed to clarify the mechanism of effect modification of the *ALDH2* rs671 polymorphism on the association between alcohol intake and blood pressure.
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